SI9111497A - Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo - Google Patents

Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo Download PDF

Info

Publication number
SI9111497A
SI9111497A SI9111497A SI9111497A SI9111497A SI 9111497 A SI9111497 A SI 9111497A SI 9111497 A SI9111497 A SI 9111497A SI 9111497 A SI9111497 A SI 9111497A SI 9111497 A SI9111497 A SI 9111497A
Authority
SI
Slovenia
Prior art keywords
monohydrate
mometasone furoate
water
common
furoate
Prior art date
Application number
SI9111497A
Other languages
English (en)
Slovenian (sl)
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9111497(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SI9111497A publication Critical patent/SI9111497A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI9111497A 1990-09-10 1991-09-09 Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo SI9111497A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
YU149791A YU48666B (sh) 1990-09-10 1991-09-09 Mometason furoat monohidrat i postupak za njegovo dobijanje

Publications (1)

Publication Number Publication Date
SI9111497A true SI9111497A (sl) 1998-04-30

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9111497A SI9111497A (sl) 1990-09-10 1991-09-09 Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo

Country Status (35)

Country Link
US (1) US6180781B1 (fr)
EP (1) EP0548114B1 (fr)
JP (1) JPH0725789B2 (fr)
KR (1) KR960013445B1 (fr)
CN (1) CN1030920C (fr)
AT (1) ATE113604T1 (fr)
AU (1) AU663471B2 (fr)
BG (1) BG60755B2 (fr)
CA (1) CA2091360C (fr)
CZ (1) CZ281318B6 (fr)
DE (2) DE19875032I2 (fr)
DK (1) DK0548114T5 (fr)
EE (1) EE02962B1 (fr)
ES (1) ES2065701T3 (fr)
FI (1) FI111078B (fr)
HK (1) HK185996A (fr)
HR (1) HRP920383B1 (fr)
HU (1) HU213401B (fr)
IE (1) IE67056B1 (fr)
IL (1) IL99437A (fr)
LU (1) LU90366I2 (fr)
MX (2) MX9203396A (fr)
MY (1) MY106644A (fr)
NL (1) NL980012I2 (fr)
NO (1) NO300548B1 (fr)
NZ (1) NZ239711A (fr)
OA (1) OA09772A (fr)
PH (1) PH30443A (fr)
PL (1) PL165803B1 (fr)
PT (1) PT98905B (fr)
SI (1) SI9111497A (fr)
TW (2) TW229208B (fr)
WO (1) WO1992004365A1 (fr)
YU (1) YU48666B (fr)
ZA (1) ZA917148B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
CA2305256C (fr) * 1997-10-09 2005-05-17 Schering Corporation Suspensions de mometasone furoate pour la nebulisation
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
WO2005051931A2 (fr) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007045980A1 (fr) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de la phosphodiesterase de type iv
CA2626612A1 (fr) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008035315A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiesterase type iv
WO2008035316A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de phosphodiestérase
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
EP2124943A1 (fr) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
CA2763939A1 (fr) 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions permettant l'administration par voie pulmonaire d'antagonistes, a action prolongee, des recepteurs muscariniques et d'agonistes, a action prolongee, des recepteurs adrenergiques b2 et methodes et systemes associes
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
KR102391332B1 (ko) 2013-03-15 2022-04-26 펄 테라퓨틱스 인코포레이티드 미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL

Also Published As

Publication number Publication date
IE913155A1 (en) 1992-03-11
NZ239711A (en) 1992-09-25
NL980012I1 (nl) 1998-05-06
MY106644A (en) 1995-07-31
PT98905A (pt) 1992-09-30
IE67056B1 (en) 1996-02-21
NO930693L (no) 1993-02-26
NL980012I2 (nl) 2004-11-01
EP0548114B1 (fr) 1994-11-02
YU48666B (sh) 1999-06-15
HRP920383A2 (en) 1998-06-30
YU149791A (sh) 1994-01-20
MX9203396A (es) 1992-07-31
OA09772A (en) 1993-11-30
ES2065701T3 (es) 1995-02-16
DE69104991T2 (de) 1995-04-20
EE02962B1 (et) 1997-02-17
NO300548B1 (no) 1997-06-16
TW272195B (fr) 1996-03-11
EP0548114A1 (fr) 1993-06-30
ZA917148B (en) 1992-08-26
CA2091360A1 (fr) 1992-03-11
US6180781B1 (en) 2001-01-30
MX9100990A (es) 1992-05-04
JPH0725789B2 (ja) 1995-03-22
HU213401B (en) 1997-06-30
DK0548114T5 (da) 1995-01-30
IL99437A0 (en) 1992-08-18
ATE113604T1 (de) 1994-11-15
CZ281318B6 (cs) 1996-08-14
PH30443A (en) 1997-05-09
HK185996A (en) 1996-10-11
PL165803B1 (pl) 1995-02-28
IL99437A (en) 1995-05-29
AU8497491A (en) 1992-03-30
DE69104991D1 (de) 1994-12-08
CN1030920C (zh) 1996-02-07
PT98905B (pt) 1998-08-31
AU663471B2 (en) 1995-10-12
TW229208B (fr) 1994-09-01
LU90366I2 (fr) 1999-05-05
DE19875032I2 (de) 2007-04-19
HUT64361A (en) 1993-12-28
HU9300685D0 (en) 1993-06-28
KR960013445B1 (ko) 1996-10-05
NO930693D0 (no) 1993-02-26
HRP920383B1 (en) 2000-04-30
FI931031A (fi) 1993-03-09
CN1059911A (zh) 1992-04-01
BG60755B2 (bg) 1996-02-29
FI931031A0 (fi) 1993-03-09
WO1992004365A1 (fr) 1992-03-19
CA2091360C (fr) 1997-04-08
FI111078B (fi) 2003-05-30
CZ38393A3 (en) 1994-01-19
JPH05506667A (ja) 1993-09-30

Similar Documents

Publication Publication Date Title
SI9111497A (sl) Mometazon furoat, postopek pridobivanja in farmacevtske oblike, ki ga vsebujejo
US6127353A (en) Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
JPH0313233B2 (fr)
US20020052379A1 (en) Gatifloxacin pentahydrate
US9981985B2 (en) Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation
CN107344955A (zh) 一种地塞米松水合物化合物
US4419358A (en) Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
EP3868768B1 (fr) Produit pharmaceutique cristallin de contezolid acéfosamil, son procédé de préparation et ses applications
WO2020078205A1 (fr) Produit pharmaceutique cristallin de contezolid acéfosamil, son procédé de préparation et ses applications
CN107141253A (zh) 一种阿立哌唑倍半水合物化合物
FI105034B (fi) Kiteinen etoposidi-4'-fosfaattidietanolaatti
WO2014023647A1 (fr) Esters de bortézomib et formulations de ceux-ci
CN110938001A (zh) 绿原酸乙醇胺盐及用途
JP2024521882A (ja) フィンゴリモド薬用塩、製造方法、それを含む医薬組成物及び使用
CN105646583A (zh) 一种稳定的头孢洛林化合物
CN113801021A (zh) 绿原酸钠水合物及其应用
CN111138282A (zh) 绿原酸l-精氨酸盐及其用途